Table 4: Mantel-Haenszel analysis between CHADVASc, HAS-BLED, GBS, Oakland scores with timing of anticoagulation resumption and our three primary outcomes.

Day of restart

(1)

(2)

(3)

(4)

(5)

(6)

(7)

(8)

1

0.9

0.28

0.87

0.27

0.449

0.04

0.197

0.59

2

N/A

0.65

0.7

0.53

0.916

0.822

0.29

0.42

3

0.65

N/A

N/A

N/A

N/A

0.833

0.79

0.37

4

0.39

N/A

N/A

N/A

N/A

0.62

0.5

0.32

5

N/A

N/A

N/A

N/A

N/A

0.388

0.09

0.22

6

N/A

N/A

N/A

N/A

N/A

0.08

0.28

0.28

7

N/A

0.59

0.755

0.68

0.342

0.14

0.68

0.34

8

N/A

N/A

N/A

N/A

N/A

N/A

N/A

0.15

9

N/A

N/A

N/A

N/A

N/A

0.15

N/A

N/A

10

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

>10

0.5

0.36

0.26

0.36

N/A

0.26

0.36

N/A

(1) CHADVASc vs. thrombotic events; (2) CHADVASc vs. mortality events; (3) HAS-BLED vs. Mortality events; (4) GBS vs. Mortality events; (5) OAKLAND vs. Mortality events; (6) HAS-BLED vs. Bleeding events; (7) GBS vs. Bleeding event; (8) OAKLAND vs. Bleeding events